Previous studies have shown that downregulation of MyD88 protein expression and NF-κB phosphorylation can ameliorate the severity of SLE (Liu et al., 2018; Wu et al., 2016; Zhan et al., 2021). This evidence concerns the gene NFKB1 and systemic lupus erythematosus.